Czech medtech KARDI AI raises €1.5M in seed funding

Czech Republic-based startup KARDI AI raises €1.5M in a seed funding round set to reshape preventive heart monitoring. Purple Ventures, DEPO Ventures, Cleverage.vc, Soulmates Ventures, Garage Angels, and other angel investors participated in the round.

• Founded in 2022 by Stephen Burke, Tomáš Skála, David Skála, and Pavel Digaňa, KARDI AI utilizes commercially available wearable heart monitors and the patients’ mobile phones to facilitate early diagnosis of health conditions. The solution leverages Artificial Neural Network, which significantly reduces the time required to interpret ECG data while simultaneously improving sample rates.

• To date, KARDI AI algorithms have checked over 250 million heartbeats. 70 cardiologists and neurologists work with the company, 150 new records are collected daily, and 600 users have already used the platform.

“At BrightCap, we strongly believe in the power of preventive medicine, and KARDI AI perfectly aligns with our vision. Leveraging the data collected from wearable devices, KARDI AI facilitates early diagnosis of health conditions, enabling more effective treatments and ultimately offering a superior lifestyle to patients,”

BrightCap Ventures, one of the previous investors, comments.

• This round, the company was backed by Central and Eastern European VCs such as Purple Ventures, DEPO Ventures, also an existing investor, Cleverage.vc, Soulmates Ventures, Garage Angels, as well as other undisclosed angel investors.

The fresh capital will allow KARDI AI to move towards its ambitious goals, including achieving EU MDR 2a compliance, further enhancing the product, and expanding its market presence.